Director Taitel Haya, a key insider at Entera Bio Ltd. ($ENTXW), made one open market purchase of common shares in the last year, totaling $11,100. The most recent buy occurred on February 10, 2026. This activity ranks 4,197th out of 4,983 individual insiders with purchases, compared to an average of $1.46 million per insider across 3.3 transactions. Haya reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 10, 2026 | Entera Bio Ltd. | $ENTX | Taitel Haya | Director | P | Ordinary Shares, par value NIS 0.0000769 per share | 7500 | $1.48 | 98,479.0000 | 47,089,814 | 8.24% | 0.02% |
| Jan. 1, 2026 | Entera Bio Ltd. | $ENTX | Taitel Haya | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 26329 | $0.00 | 90,979.0000 | 47,089,814 | 40.73% | 0.06% |
| Jan. 1, 2026 | Entera Bio Ltd. | $ENTX | Taitel Haya | Director | A | Stock Option (right to buy) | 33505 | $0.00 | 33,505.0000 | 47,089,814 | 9999.99% | 0.07% |
| Jan. 15, 2025 | Entera Bio Ltd. | $ENTX | Taitel Haya | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 6922 | $0.00 | 64,650.0000 | 37,650,179 | 11.99% | 0.02% |
| Jan. 15, 2025 | Entera Bio Ltd. | $ENTX | Taitel Haya | Director | A | Stock Option (right to buy) | 28509 | $0.00 | 28,509.0000 | 37,650,179 | 9999.99% | 0.08% |
| Oct. 2, 2024 | Entera Bio Ltd. | $ENTX | Taitel Haya | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 7278 | $0.00 | 57,728.0000 | 37,644,612 | 14.43% | 0.02% |
| Aug. 27, 2024 | Entera Bio Ltd. | $ENTX | Taitel Haya | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 15335 | $0.00 | 50,450.0000 | 29,007,794 | 43.67% | 0.05% |
| Jan. 12, 2024 | Entera Bio Ltd. | $ENTX | Taitel Haya | Director | P | Ordinary Shares, par value NIS 0.0000769 per share | 9500 | $0.99 | 35,115.0000 | 29,007,794 | 37.09% | 0.03% |
| Jan. 10, 2024 | Entera Bio Ltd. | $ENTX | Taitel Haya | Director | P | Ordinary Shares, par value NIS 0.0000769 per share | 7615 | $0.77 | 25,615.0000 | 29,007,794 | 42.31% | 0.03% |
| Jan. 1, 2024 | Entera Bio Ltd. | $ENTX | Taitel Haya | Director | A | Stock Option (right to buy) | 108333 | $0.00 | 108,333.0000 | 29,007,794 | 9999.99% | 0.37% |
| Sept. 13, 2023 | Entera Bio Ltd. | $ENTX | Taitel Haya | Director | A | Stock Option (right to buy) | 33368 | $0.00 | 33,368.0000 | 0 | 9999.99% | 0.00% |
| Aug. 22, 2023 | Entera Bio Ltd. | $ENTX | Taitel Haya | Director | P | Ordinary Shares, par value NIS 0.0000769 per share | 18000 | $0.62 | 18,000.0000 | 0 | 9999.99% | 0.00% |